West Pharmaceutical Services, Inc. Stock

Equities

WST

US9553061055

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 16:00:02 2024-07-19 EDT 5-day change 1st Jan Change
317.9 USD +0.50% Intraday chart for West Pharmaceutical Services, Inc. -1.57% -9.71%
Sales 2024 * 3.01B 4.14B Sales 2025 * 3.27B 4.49B Capitalization 23.16B 31.8B
Net income 2024 * 568M 780M Net income 2025 * 660M 906M EV / Sales 2024 * 7.48 x
Net cash position 2024 * 617M 847M Net cash position 2025 * 1.02B 1.39B EV / Sales 2025 * 6.77 x
P/E ratio 2024 *
41.3 x
P/E ratio 2025 *
36.2 x
Employees 10,600
Yield 2024 *
0.29%
Yield 2025 *
0.35%
Free-Float 96.38%
More Fundamentals * Estimated data
Dynamic Chart
Stephens Adjusts Price Target on West Pharmaceutical Services to $400 From $420 MT
West Pharmaceutical Services Amends Credit Agreement to Establish $130 Million Incremental Term Loan MT
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell Midcap Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000 Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value-Defensive Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 1000 Value Index CI
West Pharmaceutical Services, Inc.(NYSE:WST) added to Russell 3000E Value Index CI
West Pharmaceutical Services Insider Sold Shares Worth $595,404, According to a Recent SEC Filing MT
Transcript : West Pharmaceutical Services, Inc. Presents at The 44th Annual William Blair Growth Stock Conference, Jun-04-2024 08:00 AM
West Pharmaceutical Services, Inc. Introduces Daikyo Crystal Zenith® Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy CI
Transcript : West Pharmaceutical Services, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 11:20 AM
West Pharmaceutical Services Insider Sold Shares Worth $24,199,050, According to a Recent SEC Filing MT
Declaration of Voting Results of the West Pharmaceutical Services Inc CI
Bernard Birkett No Longer Have Principal Operating Officer Position of West Pharmaceutical Services, Inc CI
UBS Adjusts West Pharmaceutical Services Price Target to $390 From $375, Maintains Neutral Rating MT
More news
1 day+0.50%
1 week-1.57%
Current month-3.48%
1 month-1.29%
3 months-14.55%
6 months-7.24%
Current year-9.71%
More quotes
1 week
313.90
Extreme 313.9
332.23
1 month
313.90
Extreme 313.9
335.66
Current year
310.00
Extreme 310
413.70
1 year
310.00
Extreme 310
415.73
3 years
206.19
Extreme 206.19
475.35
5 years
120.12
Extreme 120.12
475.35
10 years
39.11
Extreme 39.11
475.35
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 15-04-23
Director of Finance/CFO 55 18-06-20
Chief Tech/Sci/R&D Officer 52 18-02-25
Members of the board TitleAgeSince
Director/Board Member 66 11-01-31
Chief Executive Officer 55 15-04-23
Director/Board Member 63 16-09-11
More insiders
Date Price Change Volume
24-07-19 317.9 +0.50% 554,640
24-07-18 316.3 -3.27% 533,798
24-07-17 327 -0.63% 291,483
24-07-16 329.1 +2.81% 366,704
24-07-15 320.1 -0.89% 443,658

Delayed Quote Nyse, July 19, 2024 at 04:00 pm

More quotes
West Pharmaceutical Services, Inc. specializes in the design, manufacture and marketing of components and systems for the containment and delivery of injectable drugs. The group offers packaging, components for syringes, cartridge systems, auto-injection devices, accessories for vials, specialty components, etc. Net sales break down by family of products as follows: - own manufactured products (81.8%); - products manufactured under contract (18.2%). Net sales are distributed geographically as follows: the United States (42.3%), Germany (16.8%), Ireland (8.7%), France (7.5%), Europe (12.1%) and other (12.6%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
317.9 USD
Average target price
395.3 USD
Spread / Average Target
+24.34%
Consensus